Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Grifols SA (NASDAQ:GRFS)

21.62
Delayed Data
As of Oct 20
 +0.17 / +0.79%
Today’s Change
14.27
Today|||52-Week Range
22.83
+34.54%
Year-to-Date
No recent news for Grifols SA.

Today’s Trading

Previous close21.45
Today’s open21.40
Day’s range21.26 - 21.95
Volume1,072,530
Average volume (3 months)591,578
Market cap$5.6B
Dividend yield0.76%
Data as of 10/20/2017

Growth & Valuation

Earnings growth (last year)+3.24%
Earnings growth (this year)--
Earnings growth (next 5 years)+10.90%
Revenue growth (last year)+2.94%
P/E ratio--
Price/Sales2.46
Price/Book3.76

Competitors

----
RDYDr.Reddy's Laborator...+0.37+1.02%
CTLTCatalent Inc+0.29+0.68%
UTHRUnited Therapeutics ...+1.95+1.64%
Data as of 10/20/2017

Financials

Next reporting dateNovember 2, 2017
EPS forecast (this quarter)$0.28
Annual revenue (last year)$4.5B
Annual profit (last year)$602.1M
Net profit margin13.47%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Joint Chief Executive Officer &
Director
Raimon Grifols Roura
Joint Chief Executive Officer &
Executive Director
Victor Grifols Deu
Corporate headquarters
Barcelona, Catalonia

Forecasts